 LONDON and RALEIGH, N.C., Jan. 04, 2022 GLOBE NEWSWIRE -- Verona Pharma plc Nasdaq: VRNA Verona Pharma, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present a company overview at the H.C. Wainwright BioConnect Virtual Conference. The presentation will be available on-demand starting at 7:00 AM EST 12:00 PM GMT on Monday, January 10, 2022. 